NSE filing, NSE: BMLL. Summary written from the filing by ALFA Finder's alert engine.
Bio Medica Laboratories Ltd: key numbers
- Share price
- ₹154.90
- Market cap
- ₹194.8 Cr
- Revenue (annual)
- ₹43.09 Cr
- Net profit (annual)
- ₹11.89 Cr
- P/E (TTM)
- 16.4×Sector 46.1×
- Promoter holding
- 67.70%
- FII holding
- 4.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bio Medica Laboratories Ltd
All →Bio Medica Laboratories Annual General Meeting
Bio Medica Laboratories Ltd announced the outcome of its 11th Annual General Meeting, where shareholders approved financial statements, director re-appointment, auditor appointment, and FII investment limits.
Bio Medica Laboratories Annual General Meeting
Bio Medica Laboratories Limited has issued a notice for its 11th Annual General Meeting, scheduled for September 28, 2026, to conduct ordinary and special business.
Bio Medica Laboratories Management Change
Bio Medica Laboratories Limited has appointed M/s. Vishakha Agrawal & Associates as the Secretarial Auditor of the company effective September 2, 2026.
Bio Medica Laboratories Other Announcement
Bio Medica Laboratories Limited has appointed M/s. Vishakha Agrawal & Associates as the Secretarial Auditor of the Company, effective from September 02, 2026.
Bio Medica Laboratories Board Meeting Outcome
Bio Medica Laboratories announced the outcome of its board meeting, approving the 11th AGM notice, book closure dates, and the appointment of a Secretarial Auditor.
Bio Medica Laboratories Annual General Meeting
Bio Medica Laboratories shareholders approved multiple resolutions via postal ballot, including the disinvestment of subsidiary Vitamax Private Limited and related party transactions. The results are official.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.